Anti-BAFF x Anti-IL17 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-BAFF and anti-IL17 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can neutralize both BAFF and IL- 17 simultaneously. It is designed for the research of Lupus Nephritis (LN); Systemic Lupus Erythematosus (SLE); Rheumatoid Arthritis (RA); Psoriasis (Ps); Ankylosing Spondylitis (AS); Psoriatic Arthritis (PA) primary Sjögren's Syndrome (pSS); Multiple Myeloma (MM) therapy.
There are currently no customer reviews or questions for Anti-BAFF x Anti-IL17 Bispecific Antibody (IgG-IgG) (BSIG-019). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS